Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1984 • 1,122 citations

Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury

1989 • 1,061 citations

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

1988 • 936 citations

Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients

1988 • 893 citations

Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981

1988 • 859 citations

Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

1985 • 836 citations

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.

1991 • 751 citations

Textbook of interventional cardiology

1994 • 717 citations

Restenosis after successful coronary angioplasty in patients with single-vessel disease.

1986 • 702 citations

Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.

1983 • 579 citations

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

1992 • 548 citations

Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis

1991 • 401 citations

Defining coronary restenosis. Newer clinical and angiographic paradigms.

1993 • 258 citations

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).

1991 • 239 citations

Novel approach to the analysis of restenosis after the use of three new coronary devices

1992 • 238 citations

Can restenosis after coronary angioplasty be predicted from clinical variables?

1993 • 189 citations

Influence of intimal dissection on restenosis after successful coronary angioplasty.

1985 • 170 citations

Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty

1991 • 159 citations

Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty

1989 • 155 citations

Restenosis after arterial angioplasty: A hemorrheologic response to injury

1987 • 153 citations

Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.

1993 • 151 citations

Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome

1988 • 147 citations

Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: A quantitative angiographic study in 1,445 successfully dilated lesions

1992 • 142 citations

Cardiac Imaging: A Companion to Braunwald's Heart Disease

1991 • 134 citations

Restenosis after coronary angioplasty: The paradox of increased lumen diameter and restenosis

1992 • 133 citations

Restenosis after coronary angioplasty: New standards for clinical studies

1990 • 131 citations

Quantitative coronary angiography

1994 • 113 citations

Pharmacologic prevention of restenosis after coronary angioplasty

1993 • 99 citations

Restenosis after transluminal coronary angioplasty: A risk factor analysis

1990 • 73 citations

Animal models of restenosis

1994 • 66 citations

Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty — A report from the M-HEART Groupt

1990 • 64 citations

Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris

1989 • 44 citations

Cardiac Imaging: A Companion to Braunwald's Heart Disease

1991 • 33 citations

Patient, Lesion, and Procedural Variables as Risk Factors for Luminal Re-Narrowing After Successful Coronary Angioplasty

1993 • 31 citations

Recurrence of stenoses after coronary angioplasty.

1986 • 21 citations

Comparison of Diltiazem Standard Formulation and Diltiazem Controlled Release in Patients with Stable Angina Pectoris

1993 • 18 citations

Restenosis after balloon dilatation of coronary stenosis multivariate analysis of potential risk factors

1988 • 17 citations